Schouten Olaf, van Waning Virginie H, Kertai Miklos D, Feringa Harm H H, Bax Jeroen J, Boersma Eric, Elhendy Abdou, Biagini Elena, van Sambeek Marc R H M, van Urk Hero, Poldermans Don
Department of Vascular Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Am J Cardiol. 2005 Sep 15;96(6):861-6. doi: 10.1016/j.amjcard.2005.05.036.
The aim of the present study was to determine the perioperative and long-term cardiac outcomes of patients who underwent elective open or endovascular major vascular surgery corrected for cardiac risk factors and dobutamine stress echocardiography. Consecutive patients who underwent either endovascular (n = 123) or open (n = 560) vascular surgery from 1996 to 2004 at Erasmus Medical Center were enrolled. Patients were screened for cardiac risk factors (advanced age, gender, angina pectoris, myocardial infarction, heart failure, diabetes, stroke, renal failure), cardioprotective medication, and the presence of stress-induced ischemia by dobutamine stress echocardiography. Postoperative data on troponin release and electrocardiography were routinely collected on days 1, 3, and 7 and before discharge. After discharge, patients were regularly screened at the outpatient clinic. The main outcome measures were perioperative and long-term cardiac death and myocardial infarction. The incidence of perioperative cardiac events was significantly less in endovascular-treated patients compared with conventionally treated patients, also after adjustment for clinical risk factors, dobutamine stress echocardiography, and medication (hazard ratio [HR] 0.19, 95% confidence interval [CI] 0.07 to 0.53). In contrast, during long-term follow-up (median 3.8 years, range 0 to 8.4), the incidence of long-term cardiac mortality and myocardial infarction were similar in the 2 groups (HR 0.89, 95% CI 0.52 to 1.52). In conclusion, endovascular stent grafting is associated with a reduced incidence of perioperative complications compared with open vascular surgery. Despite the initial perioperative survival benefit, patients who undergo endovascular surgery remain at high risk for late cardiac events.
本研究的目的是确定接受择期开放性或血管腔内大血管手术且已针对心脏危险因素及多巴酚丁胺负荷超声心动图进行校正的患者的围手术期和长期心脏结局。纳入了1996年至2004年在伊拉斯谟医疗中心接受血管腔内手术(n = 123)或开放性手术(n = 560)的连续患者。对患者进行心脏危险因素(高龄、性别、心绞痛、心肌梗死、心力衰竭、糖尿病、中风、肾衰竭)、心脏保护药物以及通过多巴酚丁胺负荷超声心动图筛查应激性心肌缺血情况的评估。术后第1天、第3天、第7天及出院前常规收集肌钙蛋白释放及心电图的相关数据。出院后,在门诊对患者进行定期筛查。主要结局指标为围手术期和长期心脏死亡及心肌梗死。与传统治疗的患者相比,血管腔内治疗患者围手术期心脏事件的发生率显著更低,在对临床危险因素、多巴酚丁胺负荷超声心动图及药物进行校正后亦是如此(风险比[HR] 0.19,95%置信区间[CI] 0.07至0.53)。相比之下,在长期随访期间(中位时间3.8年,范围0至8.4年),两组的长期心脏死亡率及心肌梗死发生率相似(HR 0.89,95% CI 0.52至1.52)。总之,与开放性血管手术相比,血管腔内支架植入术与围手术期并发症发生率降低相关。尽管血管腔内手术在围手术期有生存获益,但接受血管腔内手术的患者后期心脏事件风险仍然很高。